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ABSTRACT
International Journal of Exercise Science 13(3): 1583-1594, 2020. The purpose of this study was to

assess changes in pain and physical activity after replacing a traditional spinal cord stimulation (SCS) implantable
pulse generator with a next generation SCS in patients for whom traditional SCS was no longer providing adequate
relief of low back and/or leg pain. Subjects (n = 19) who reported that they were no longer receiving adequate relief
from traditional SCS were implanted with a next generation SCS. Eighteen additional patients who were receiving
relief from traditional SCS were also followed as a control. Both groups (next generation, traditional) were assessed
for low-back and limb pain (visual analog scale) and daily physical activity (wearable accelerometer) at baseline
and three, six, nine and 12 months following the SCS implant. Relative to baseline, next generation SCS subjects
exhibited reductions (p ≤ 0.05 for all) in low-back pain (average reduction of 22%) at every time point, in leg pain
(average reduction of 23%) at every time point except six months and increased physical activity (average increase
of 57%) at three, six and nine months. As expected, there were no changes in pain or physical activity in the
traditional SCS subjects (p ≥ 0.1). In conclusion, pain decreased, and physical activity increased in patients receiving
a next generation SCS. Physical activity may serve as an objectively measured marker of pain.
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INTRODUCTION
Chronic pain in the lower back and/or limbs affects millions of Americans (25, 37, 41).
Treatments may include, but are not limited to, epidural steroid injections, physical therapy,
smoking cessation, weight loss, medications, and surgery (9, 10, 34). While there is evidence
supporting the efficacy of these treatments in the management of lower back and/or limb pain,
the relief they provide is often short-lived, and/or may require repeated treatments. It is also
common, especially in the case of back surgery, that these treatments fail (8).
Because the treatment of low-back/limb pain is complicated and often short-lived, there is a
need for novel approaches which may provide enduring relief. While spinal cord stimulation
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(SCS) is not a new therapy, advances in medical technology have led to the development of
novel SCS devices that warrant investigation (14, 26, 35, 38). SCS therapy, which has been
utilized for >40 years, is the surgical implantation of an electrode in the epidural space (14, 26,
35, 38). This electrode is connected to an implantable electrical pulse generator (IPG) which
provides electrical stimulation to the spinal cord, stimulating the dorsal column neurons that
correspond to the affected area of the patient’s pain. This electrical stimulation causes
paresthesia in the affected area which reduces pain sensation (30, 38). While multiple studies
have demonstrated a significant reduction in lower back and lower limb pain with SCS for
patients with failed back surgery syndrome (FBSS) versus those not receiving SCS, these effects
can often be incomplete and transient (20, 24, 26, 29). New or next generation SCS units are
designed to provide variable stimulation with an algorithm that accounts for the three
dimensional space of the leads within the spinal canal (22, 23). As a result, this algorithm may
provide a physician the ability to program SCS with greater precision and flexibility compared
to traditional SCS systems. This enhanced neural targeting may improve the efficacy of next
generation SCS therapy over traditional devices.
While evaluating the efficacy of novel therapies to treat low back pain is warranted, how this
research quantifies efficacy is also important to consider. A potential shortcoming of the
majority of studies examining low back pain treatments, especially those utilizing SCS, is a focus
primarily upon subjective pain scores (14, 35, 38). While pain scores are important when
evaluating the efficacy of low back pain treatment, we believe future studies should include
greater focus upon objectively assessed functional measures as a way of quantifying medical
efficacy. One such functional measure, physical activity, can be assessed objectively and may
provide a window into an individual’s physical well-being (19). Pain is self-limiting meaning
that during a period when an individual is experiencing pain physical activity will typically be
limited (2). Therefore, if pain is alleviated, it is likely that physical activity would increase. In
this way, physical activity may serve as an objective, albeit indirect, marker for pain.
In addition to being a potential marker for pain, physical activity may also serve as a treatment
for individuals with low back pain. Numerous studies have indicated that physical activity is
inversely associated with a number of pain disorders including low-back pain, fibromyalgia,
diabetes, and migraine (1, 6, 18, 27). In other words, a lack of physical activity is associated with
a greater likelihood of having a pain disorder. If pain is alleviated medically and this results in
increased physical activity, that greater activity may then have a protective effect against pain
resumption (27). There is also evidence that reductions in pain and greater physical activity may
have additional positive effects on other measures of psychological health such as anxiety,
depression and quality of life which are common problems in individuals with pain disorders
(3, 12, 13, 16, 33, 36, 40).
The purpose of this study was to examine the effect of next generation SCS therapy on the
following variables: objectively-measured physical activity, self-reported pain, anxiety,
depression, and quality of life in a group of patients with low back and/or limb pain for whom
traditional SCS was no longer providing adequate relief. In addition to examining a group of
patients who had their traditional SCS replaced with a next generation SCS we also followed a
group of patients for whom traditional SCS was providing adequate relief. This traditional
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group was then compared to the next generation group. The individuals who were satisfied
with their traditional device were included as a refence group in the present study as it was
hypothesized that these individuals may represent a desired clinical outcome for the patients
undergoing revision to next generation SCS. Because they were satisfied with their device, we
hypothesized that this group retaining their traditional SCS would report lower pain and be
more physically active than the next generation SCS group at baseline. We then hypothesized
that these differences would abate over time as the next generation group, relative to baseline,
would report decreased pain scores and participate in greater amounts of physical activity. Were
these hypotheses to occur and the next generation SCS patients increase physical activity and
decrease pain scores to levels that were similar to those who were satisfied with their traditional
SCS device, this could be considered a positive clinical outcome for the next generation SCS
patients as it pertains to pain scores and physical activity.
METHODS
Participants
Participants were recruited from a pool of patients that were receiving care for low back and/or
leg pain and were eligible for removal of a traditional SCS IPG and subsequent re-implantation
with a next-generation SCS IPG utilizing three-dimensional neural targeting. These patients had
all been implanted with the traditional 16 contact SCS IPG (St. Jude Medical Inc. Rechargeable,
St. Paul, MN) ≤18 months prior to the start of the present study. Patients were eligible for
removal of this traditional SCS as this device was undergoing a factory recall. The initial pool
consisted of 103 patients (58.1 ± 12.4 years of age, n = 49 female, 54 male) eligible for removal of
their traditional SCS IPG and replacement with the next generation SCS IPG (Boston Scientific
Precision Spectra™ SCS System, Valenica, CA). Of the 103 eligible patients, 31 elected to
undergo surgical revision to the next generation SCS IPG. Only the SCS IPG was replaced and
the original leads (which included below percutaneous and paddle leads) were not removed or
revised. These 31 patients elected revision to the next generation SCS as they were dissatisfied
with the traditional SCS (i.e., it was not providing adequate relief) and not because the
traditional device had failed. Of those 31 patients undergoing revision to the next generation
SCS device, 19 agreed to participate in this study (55.6 ± 10.2 years of age, 1.70 ± 0.09 m height,
97.6 ± 18.1 kg weight n = 9 female, 10 male). Prior research (21) examining the efficacy of the
next generation SCS demonstrated a significant reduction in pain (via VAS) from preimplantation to 12 months post-implantation of 33.6 ± 12.2%. A difference of this size yields an
effect size of 2.8. Given this effect size, an α of 0.05 and a power of 0.80, only four pairs of
participants would be necessary to demonstrate significance. However, in the prior study the
participants did not previously have a SCS device implanted. The magnitude of the
improvements for patents in the next generation SCS group in the current study was heretofore
unknown. Our current sample size (n = 19) of patients implanted with the next generation SCS
represents a 4.75-fold greater sample size than was required to demonstrate significant pain
reduction in the previous study. Even with attrition by month 12 of the study we still had a
sample (n = 14) that was 3.5-fold greater than the minimum as indicated by a-priori power
analysis. Therefore, we feel that that our sample size was more than adequate to detect any
significant changes in perceived pain in the proposed study.
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Of the 72 patients that elected to forgo SCS unit revision and keep their traditional device
because they were satisfied with the relief they were receiving, 18 agreed to participate in the
study (54.8 ± 14.5 years of age, 1.68 ± 0.10 m height, 84.3 ± 15.5 kg weight, n = 10 female, 8 male).
Written informed consent was obtained from all participants and all procedures and
assessments were approved by the University Institutional Review Board. Additionally, this
research was carried out fully in accordance to the ethical standards of the International Journal
of Exercise Science (28).
Protocol
Baseline assessments were performed after informed consent was obtained. Dependent
variables were collected at baseline and three, six, nine and 12 months. Baseline assessments for
patients who elected to receive the next generation SCS IPG occurred the week prior to surgical
replacement of their traditional SCS device. Baseline assessments for patients who elected to
retain their traditional SCS device were taken at the time that they consented to participate in
the study. At each visit (baseline, three, six, nine and 12 months) bodyweight, and physical
activity, as well as self-reported pain, anxiety, depression, and quality of life were assessed.
Approximately one week after completing baseline assessments, the next generation group (n =
19) underwent outpatient surgery to replace their traditional SCS IPG with the next generation
SCS IPG. Patients were placed in the prone position with the area over the pre-existing SCS IPG
exposed Monitored Anesthesia Care was provided to ensure patient comfort and standard
sterile techniques were used. Adequate location anesthesia was obtained prior to incision. A
small incision was created at the previously implanted SCS IPG. Once the current system was
identified, the anchoring sutures were removed, and the traditional system expelled from the
body. The leads were loosened from the previous SCS IPG with care to not damage them. Those
leads were left in and were then anchored into the newly implanted next generation SCS IPG.
Impedances and connections were checked by a company representative in the operating room.
Once connections were satisfactory, the leads were anchored into place. The next generation SCS
IPG was then anchored into the pre-existing tissue pocket followed by multi-layer closure of the
fascia and skin. The procedure lasted approximately 40 minutes from incision to closure and
there were no adverse incidents.
Bodyweight was assessed to the nearest kg using a balance beam scale (Health O Meter,
Chicago, IL) at each visit. At each visit participants were given a validated, wrist-mounted
accelerometer (Movband, DHS Group, Houston, TX) to wear for two weekdays and one
weekend day, for a minimum of 10 hours each day, during the week after that visit (4).
Participants were also given a daily log in which to record the days and times that the
accelerometer was worn. Participants then returned the accelerometer and log to the clinic using
a postage-paid envelope that was provided to them. Upon receiving the accelerometer in the
mail, research personnel recorded the total activity counts per day that the device was worn.
Total daily counts across all three days were summed then divided by the total number of
minutes that the device was worn over the three days and counts·min-1 the device was worn
was calculated as the measure of physical activity. This process was repeated for each time point
(baseline, three, six, nine and 12 months). Assessing physical activity for a minimum of one week
day and one weekend day predicts >90% of the variance in total weekly physical activity (39).
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Therefore, the current assessment of two weekdays and one weekend days provides a valid
assessment of physical activity behavior.
During each visit, participants were asked to report their pain in three separate areas: low back,
left leg and buttock and right leg and buttock, utilizing a validated VAS pain scale ranging from
0 (“no pain at all”) to 10 (“unbearable, excruciating pain) (32). The two lower-limb scores (left
leg and buttock and right leg and buttock) were then averaged and reported as a single lowerlimb pain score.
Participants completed the Quality of Life Scale (QOLS) during each visit. The QOLS is a
commonly utilized survey for tracking health outcomes for patients with chronic disease such
as those with FBSS (17). The questionnaire consists of 16 items that assess the following domains:
material and physical well-being, relationships with other people, social, community and civic
activities, personal development and fulfillment, recreation and independence (5).
Participants completed the Beck Depression and Anxiety inventories during each visit. The Beck
Anxiety inventory consists of 21 items for which patients assign a numeric value to (0, 1, 2, or
3). Those individual numeric values are summed as an index of anxiety. The Beck Depression
inventory similarly consists of 21 items to which patients assign a numeric value to (0, 1, 2, or
3). Those values are also summed as an index of depression (15).
Statistical Analysis
Three, six, nine and 12 month results were compared to baseline for each group (traditional,
next generation) separately for the following dependent variables: physical activity
(accelerometer counts·min-1), pain VAS (lower limb, lower back), body weight, and anxiety,
depression and quality of life scores. Independent samples t-tests were then used to compare
the next generation participants to the traditional participants at each time point (baseline, three,
six, nine and 12 months). T-tests were selected over other analytic techniques (e.g., ANOVA) as
there was attrition over the 12-month study. Using the present approach allowed for the analysis
of all subjects for the entire time that they participated in the study.
RESULTS
Bodyweight
Participants in the next generation group were significantly heavier than the traditional group
at baseline, six, nine and 12 months (p ≤ 0.03, Cohen’s d = 0.78 – 0.99, Table 1). There were no
significant changes in bodyweight at any time point in either group (p ≥ 0.3).
Physical activity
Relative to baseline, participants in the next generation group accumulated 77%, 49%, 44% and
53% more accelerometer counts·min-1 at three, six, nine and 12 months, respectively (Table 1).
These were significant increases at each time point (p ≤ 0.03, d = 0.59- 0.94) except for 12 months
which was trending towards significance (p = 0.059, d = 0.60). Participants in the traditional
group did not significantly alter physical activity nor were there any differences between groups
(p ≥ 0.1).
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Lower back pain
Relative to baseline, participants in the next generation group reported 21%, 18%, 28% and 19%
reductions in low back pain at three, six, nine and 12 months, respectively (Table 1). These were
all significant reductions (p ≤ 0.03, d = 0.55 – 0.90). Participants in the next generation group
reported significantly greater lower back pain than the traditional group at baseline (p = 0.02, d
= 0.84) but no other time points. The traditional group did not alter lower back pain scores at
any time point (p ≥ 0.3).
Lower limb pain
Relative to baseline, participants in the next generation group reported 25%, 29% and 24% less
limb pain at three, nine and 12 months, respectively (Table 1). These were all significant
reductions (p ≤ 0.05, d = 0.50 – 0.67). These participants also reported a 15%, non-significant
reduction in pain at six months (p = 0.1, d = 0.39). Participants in the next generation group
reported significantly greater lower limb pain than the traditional group at baseline and six
months (p ≤ 0.03, d = 0.72 – 1.05) but no other time points. The traditional group did not alter
lower limb pain scores at any time point (p ≥ 0.3).
Table 1 lists the mean ± standard deviation for weight, VAS (lower limb and back), and physical
activity (counts·min-1) for both the next generation and traditional groups at three, six, nine and
12 months relative to the corresponding baseline value. The sample size for each comparison is
listed for each group. Note that the sample size did decrease over the course of the study as
some participants decided to withdraw from the study as they no longer wished to participate
in follow-up appointments.
Table 1. Weight (kg), VAS (lower limb and back), and physical activity (counts·min-1).
VAS Pain
VAS Pain
Weight (kg)
Low Limb
Low Back
Next Generation
Baseline (n = 19)
97.6±18.1
5.6±2.1
7.2±2.1

Traditional

Physical activity
(counts·min-1)
7.0±6.1

Three months

91.7±26.0

4.2±2.1*

5.7±2.5*

12.4±10.4*

Baseline (n = 18)
Six months
Baseline (n = 16)
Nine months

97.4±18.6
97.3±19.3
98.8±19.1
99.5±20.4

5.5±2.1
4.7±1.9
5.6±2.2
4.0±2.4*

7.2±2.2
5.9±1.9*
7.2±2.3
5.2±3.1*

7.3±6.2
10.9±7.4*
7.1±6.3
10.2±8.0*

Baseline (n = 14)
12 months

97.7±20.0
99.3±21.6

5.8±2.3
4.4±2.5*

7.5±2.3
6.1±2.3*

6.0±4.2
9.2±6.7

Baseline (n = 18)
Three months
Baseline (n = 16)

84.3±15.5†
84.1±15.9
83.8±13.7

3.4±2.2†
3.4±2.7
3.5±2.4

5.1±3.2†
4.6±3.3
5.1±3.2

7.2±4.1
7.6±5.1
7.6±4.0

Six months
Baseline (n = 16)

83.4±14.4†
83.8±13.7

3.0±2.4†
3.5±2.4

4.8±3.0
5.1±3.2

9.7±8.0
7.5±4.1

Nine months
82.6±15.8†
3.9±2.9
4.6±3.3
7.6±6.6
Baseline (n = 15)
82.3±12.8
3.4±2.4
4.9±3.2
7.4±4.5
12 months
81.0±16.5†
3.6±2.5
4.5±3.4
7.2±4.7
*Significantly (p≤0.05) different from baseline. †Significantly (p≤0.05) different from the next generation group at the
same time point.
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Quality of life
Participants in the traditional group reported greater quality of life scores than next generation
participants at baseline (p = 0.03, d = 0.75) but at no other time point (Table 2). Relative to
baseline, participants in the next generation group reported a significant, 8% increase in quality
of life at nine months (p = 0.035, d = 0.58). There were no other differences in quality of life for
either group or between groups (p ≥ 0.15).
Anxiety
Relative to baseline, participants in the next generation group reported reductions in anxiety
scores of 31%, 24%, 39% and 26% at three, six, nine and 12 months, respectively (Table 2). These
were all significant reductions (p ≤ 0.04, d = 0.53 – 0.85). Participants in the next generation group
reported significantly greater anxiety than the traditional group at baseline (p = 0.024, d = 0.79)
but no other time points. The traditional group did not alter anxiety scores at any time point (p
≥ 0.3).
Depression
Relative to baseline, the next generation group reported 23% and 20% lower depression scores
at six and nine months, respectively (Table 2). These reductions were statistically significant (p
≤ 0.05, d = 0.55 – 0.62). These participants also exhibited non-significant decreases in depression
of 16% at both three and 12 months (p ≥ 0.06, d = 0.46). Participants in the traditional group did
not significantly (p ≥ 0.1) alter depression scores nor were there any differences between groups.
Table 2 lists the mean ± standard deviation for quality of life, anxiety, and depression scores for
both the next generation and traditional groups at three, six, nine and 12 months relative to the
corresponding baseline value. The sample size for each comparison is listed for each group.
Table 2. Quality of life, anxiety, and depression scores.

Next Generation

Traditional

Baseline (n = 18)
Six months
Baseline (n = 16)
Nine months

Quality of Life
score
70.3±11.5
73.4±12.9
71.8±9.5
76.9±15.7
71.4±9.3
77.4±10.8*

Baseline (n = 14)
12 months

71.3±8.4
77.1±14.9

20.4±10.6
15.1±10.2*

14.5±12.2
12.2±7.2

Baseline (n = 18)
Three months
Baseline (n = 16)

80.4±16.0†
80.1±19.1
78.8±16.2

13.9±9.5†
13.6±12.1
14.7±9.7

11.2±10.1
11.4±8,8
11.8±10.6

Six months
Baseline (n = 16)

80.9±18.8
78.8±16.2

14.1±12.8
14.7±9.7

13.2±11.0
11.8±10.6

Baseline (n = 19)
Three months

Anxiety Score

Depression Score

21.6±10.2
14.9±8.0*
21.6±10.5
16.4±9.5*
21.8±10.8
13.4±9.2*

16.3±13.7
13.7±7.3
15.8±12.2
12.2±6.7*
16.3±13.1
13.1±6.9*

Nine months
83.9±19.7
14.3±13.3
10.9±9.6
Baseline (n = 15)
78.3±16.6
14.7±10.0
11.9±10.9
12 months
81.4±20.0
12.2±12.5
11.9±11.7
*Significantly (p≤0.05) different from baseline. †Significantly (p≤0.05) different from the next generation group at the same
time point.
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DISCUSSION
This is the first study of which we are aware to examine the effect of replacing a traditional SCS
IPG, which was no longer providing adequate relief, with a next generation device using threedimensional neural targeting on objectively measured physical activity, self-reported pain, and
psychological well-being. At baseline, before receiving the new device, participants in the next
generation SCS group reported greater pain and anxiety than those in the traditional group who
elected not to alter their SCS device. After receiving the next generation device, these
participants exhibited significant reductions in pain (back and lower limb) ranging from 18-29%
and anxiety scores ranging from 24 to 31%, such that they were no longer greater than those for
traditional SCS patients. Apart from one time point (six months) for lower limb pain, these
improvements in anxiety and pain scores in the next generation group persisted throughout the
entire 12-month study. Furthermore, these reductions are either within or exceeded the range of
scores for minimum clinically important difference for improvements in both pain (13-85%
change) and anxiety (17.5%) (7, 31).
While it is common to assess self-reported pain in interventions designed to treat lower
back/limb pain (14, 35, 38), the assessment of physical activity as an outcome is novel. Presently,
in the next generation SCS patients, we noted increases in physical activity of 40% or more than
baseline at every time point where pain was reduced. Prior research has indicated that a
minimally important difference in physical activity can range from ~17 – 29% (11). Therefore,
the next generation SCS group’s increases in physical activity would exceed this threshold. Each
of these increases in physical activity in the present study were statistically significant apart
from the 12-month time point which was trending (p = 0.059) towards significance. Conversely,
those patients in the traditional SCS group exhibited no changes in physical activity or pain.
This finding supports our hypothesis that patients would exhibit concomitant reductions in pain
and increases in physical activity with treatment.
The pain relief and increased physical activity with next generation SCS revision reported herein
is accompanied by additional positive outcomes, including reduced anxiety and depression
along with increased quality of life. While these additional changes may be the result of
decreased pain, increased physical activity could also positively affect these variables. Increased
physical activity, which may aid in maintaining reduced self-reported pain (2), is inversely
associated with anxiety, depression and low back pain (3, 13, 16, 36). In other words, individuals
who are more physically active often report lower anxiety, depression, and low back pain than
their less-active peers. There is also experimental evidence supporting the notion that
participating in physical activity can cause an anti-anxiety and anti-depressant effect (36).
Physical activity is also positively associated with quality of life (12, 33) such that physically
active individuals, relative to their less active peers, exhibit a greater quality of life. Therefore,
physical activity may act as a feed-forward mechanism through which the effects of pain relief
on these other variables is maintained or enhanced. Even if physical activity is only a marker for
decreased pain, this present finding is still potentially important as physical activity can be
measured objectively whereas pain is subjective. Providing objective outcomes for the
assessment of pain interventions may aid in the study of the efficacy of such interventions.
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Future research on the importance of physical activity assessment in interventions designed to
provide relief from pain is therefore warranted.
While this study yields novel information, it is not without limitations. Foremost, this was a
small sample to begin with and attrition added to this problem. It is important to note that
participants who withdrew from the study did so because they did not wish to attend any
further follow-up appointments and not because there were any adverse events with either the
next generation or traditional SCS devices. Another limitation was participants self-selected
which group they would be in. Therefore, this is not a true experiment and our ability to infer
causality is limited. Participants in the next generation group were dissatisfied with their
traditional device whereas the traditional group was receiving adequate relief. It is not clear
why some individuals received adequate relief with traditional SCS, and others did not. Future
studies examining the efficacy of SCS unit revision should include larger samples and
randomized control and experimental groups.
In conclusion, this is the first study we are aware of to assess the pain-relieving effects of SCS
revision from a traditional device to a next generation device which may allow for more specific
neural targeting. This is also the first study to assess the effect of any SCS therapy upon
objectively measured physical activity behavior. Patients who were no longer receiving
adequate relief with traditional SCS therapy exhibited decreased pain, anxiety, and depression
and increased physical activity and quality of life after receiving a next generation SCS device.
It is possible increased physical activity may be a marker for decreased pain and could provide
further relief from symptoms common to patients with low back pain. Future research that
utilizes experimental designs and assesses physical activity as an outcome measure of the
efficacy of treatments for pain disorders is warranted.
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